Project Number 5R21AG070843-02 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Glysocaminoglycan Modifications as Regulators of Alzheimer's Disease-Related Pathologies Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 6. Autophagy, Endocytosis and Membrane Trafficking a. Proteostasis Researcher and Organization Principal Investigator SELLECK, SCOTT B Principal Investigator First Name SCOTT B Principal Investigator Last Name SELLECK Awardee Organization PENNSYLVANIA STATE UNIVERSITY Awardee State Pennsylvania Contact PI Country United States Project Detail Funding Opportunity Announcement PA-20-195: NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) FY Overall Cost $197,738 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official YANG, AUSTIN JYAN-YU
